TrialJournal of affective disorders2024

Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression.

Patricia Andrews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.